The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors - Ungefroren, H; Sebens, S; Groth, S; Gieseler, F; Fandrich, F (Curr Cancer Drug Targets, 2011)